Found 144 matching trials
Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma PHASE2 This Phase II non-randomized study is to determine the efficacy and toxicit...
Show More Location
Sun yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC PHASE2 This is a single-center, single-arm, phase II clinical study to evaluate th...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer PHASE2 Neoadjuvant chemoradiotherapy (CRT) followed by surgery has become the stan...
Show More Learn More & Join Trial
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy PHASE3 This prospective trial aims to enroll patients with high-risk stage III-IVA...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients PHASE2 This trial is a phase II clinical trial of the safety and efficacy of PD-1 ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE2 This is a multicenter, prospective, randomized, controlled Phase II trial e...
Show More Location
The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital)
Learn More & Join Trial
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC PHASE2 This phase II randomized trial evaluates PD-1 inhibitor plus chemotherapy f...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) PHASE2 The purpose of the research is to test the safety and efficacy of the inves...
Show More Location
Stanford University
Learn More & Join Trial
Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma PHASE2 This study is to investigate the efficacy and safety of the induction chemo...
Show More Location
Multiple Locations
Learn More & Join Trial